Skip to main content

Genetic Test

Genetic test eliminates progressive retinal atrophy in English shepherd dogs



Researchers at the University of Cambridge recently published their findings in Genes after identifying the genetic mutation that is causing progressive retinal atrophy (PRA) in English shepherd dogs. PRA is a group of inherited diseases causing progressive degeneration of the light sensitive cells within the back of the eyes. When it comes to PRA in dogs, they are born with normal vision but by the age of 4-5 they go totally blind with no treatment.

According to the release, by identifying the canines carrying this disease before they lose vision, this can be then used as a tool to guide breeding decisions to prevent the passing of the disease onto puppies.1 Historically, owners did not realize their dog had PRA until they were middle-aged, which means it could have been passed on to puppies if they had bred, making this a hard disease to control.

“Once the dog’s eyesight starts to fail there’s no treatment – it will end up totally blind,” said Katherine Stanbury, BSc, PhD, a researcher in the University of Cambridge’s Department of Veterinary Medicine and first author of the report.1 “Now we have a DNA test, there’s no reason why another English Shepherd Dog ever needs to be born with this form of progressive retinal atrophy – it gives breeders a way of totally eliminating the disease.”

The team discovered the genetic mutation causing the disease is recessive, meaning English shepherd dogs can only suffer this blindness if they inherit 2 copies of the gene. For breeding, if a dog only has 1 copy, this makes the dog a carrier and it will not develop PRA but can pass it onto its puppies. If 2 of these carriers are bred together, almost 1 in 4 puppies will be affected. Because dogs are ‘very inbred,’ many individuals are related, giving them a higher chance of being affected by recessive disease when compared to humans.1

The inspiration behind the study came after the team was contacted by a distraught owner of an English shepherd dog, who was diagnosed with PRA. This dog was working as a search and rescue dog but had to retire due to visual deterioration that caused total blindness.


To complete the study, researchers put out a call for DNA samples from other owners or breeders, receiving 6 samples with PRA and 20 without. This gave them enough information to pinpoint the genetic mutation causing PRA using whole genome sequencing. With these findings, PRA can be completely eliminated from English shepherd dog populations quickly.1

The team is offering commercial canine genetic testing services to breeds to help them avoid breeding canines that will develop inherited diseases. These tests will now offer a DNA test for Progressive Retinal Atrophy in English Shepherds that can be bought for £48, a little over 61 USD. Anyone can buy these tests and all that has to be done is pet parents or veterinary professionals will need to swab the inside of the dogs mouth and send it back to the lab for testing.

“An owner won't necessarily notice their dog has got anything wrong with its eyes until it starts bumping into the furniture. Unlike humans who will speak up if their sight isn’t right, dogs just have to get on with things,” explained Cathryn Mellersh, BSc, PhD, University of Cambridge’s Department of Veterinary Medicine, senior author of the report.

“For the price of a decent bag of dog food people can now have their English Shepherd tested for Progressive Retinal Atrophy prior to breeding. It’s about prevention, rather than a cure, and it means a huge amount to the people who breed these dogs. They no longer need to worry about whether the puppies are going to be healthy or are going to develop this horrible disease in a few years’ time,” she concluded.1

This discovery is the 33rd genetic mutation causing an inherited disease in canines that the researchers found, and out of those 33, 23 cause eye diseases. These findings highlight the fact the health and wellbeing of canines has been compromised due to how they have been bred by humans.

The researchers believe that their work with dogs can help provide clarity of the human version of the disease as well as identify targets for gene therapy in the future.


International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: x-i.me/gennom1
Award registration: x-i.me/genreg2
Member Nomination: x-i.me/genmember
Member Registration: x-i.me/genreg1
For Enquiries: genetics@healthcarek.com


Get Connected Here
---------------------------------
---------------------------------

Pinterest: x-i.me/genpt
Twitter: x-i.me/gentw
Facebook: x-i.me/genfb
Instagram: x-i.me/genin
Youtube: x-i.me/genyt
Blogger: x-i.me/genbl

Comments

Popular posts from this blog

Genetics role in ovarian cancer

The Medical Minute: Genetics play big role in ovarian cancer In 2024, about 19,680 women in the United States will receive a new diagnosis of ovarian cancer and 12,740 women will die from the disease, said Dr. Shaina Bruce , a gynecologic oncologist at Penn State Cancer Institute . The median age of all patients who develop ovarian cancer is 63. Historically, women at increased risk for ovarian cancer are recommended to have their fallopian tubes and ovaries removed when they have completed having children. Taking that step to protect themselves comes at a heavy price ― surgical menopause. But Bruce said medical science is catching up with ovarian cancer. Studies could lead to new methods for preventative care and the surgery needed to lower risk may be easier than it once was. Below, during Gynecologic Cancer Awareness Month, Bruce discusses the disease and why acting to reduce your risk is worth it. What’s the connection between heredity and ovarian cancer? About 25% of all cases of ...

X chromosome

Gene on the X chromosome may help explain high multiple sclerosis rates in women Brain inflammation may be fueled by a gene on the X chromosome, a new study in mice suggests. And in female mice, who carry two X chromosomes, a diabetes drug called metformin may work to counteract that inflammation. If these findings bear out in later studies, they could help to unravel the long-standing mystery of why women, who have two copies of this inflammation-driving gene, are more prone to certain autoimmune diseases, particularly after menopause. A disparity between the sexes Our bodies are patrolled by immune cells that provide protection against bacteria and viruses, but sometimes, these defenses turn on us. In the autoimmune disorder multiple sclerosis (MS), for instance, the immune system attacks myelin, the fatty insulation surrounding the nerve fibers in the brain and spinal cord. This leads to symptoms such as muscle weakness and difficulty walking, as well issues with memory and thinking...

Multifactorial Genetic Conditions

Multifactorial Genetic Conditions Multifactorial genetic conditions are disorders caused by the combined effects of multiple genes and environmental factors , rather than a single gene mutation . These conditions do not follow classic Mendelian inheritance patterns and instead result from complex gene–environment interactions . Factors such as lifestyle, nutrition, infections, stress, and exposure to toxins can significantly influence disease onset and severity in genetically susceptible individuals. Common examples include diabetes, cardiovascular diseases , neural tube defects, asthma, and many neuropsychiatric disorders. Understanding multifactorial inheritance is essential for risk prediction, preventive medicine, and personalized healthcare strategies. Multifactorial inheritance, polygenic traits, gene–environment interaction, complex diseases, genetic susceptibility, environmental risk factors, non-Mendelian inheritance, disease predisposition, polygenic risk score, precision ...